-
Something wrong with this record ?
Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation
J. Muchová, V. Hearnden, L. Michlovská, L. Vištejnová, A. Zavaďáková, K. Šmerková, S. Kočiová, V. Adam, P. Kopel, L. Vojtová
Language English Country Great Britain
Document type Journal Article
Grant support
17-29874A
Ministerstvo Zdravotnictví Ceské Republiky
CZ.02.1.01/0.0/0.0/16_019/0000787
Ministerstvo Školství, Mládeže a Tělovýchovy
CEITEC VUT/FEKT-J-20-6146
Vysoké Učení Technické v Brně
CZ.02.1.01/0.0/0.0/16_025/0007314
European Regional Development Fund
NV17-29874A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
BioMedCentral
from 2003-12-01
BioMedCentral Open Access
from 2003
Directory of Open Access Journals
from 2003
Free Medical Journals
from 2003
PubMed Central
from 2003
Europe PubMed Central
from 2003
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2003-01-01
Open Access Digital Library
from 2003-01-01
Medline Complete (EBSCOhost)
from 2003-01-28
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2003
Springer Nature OA/Free Journals
from 2003-12-01
- MeSH
- Anti-Bacterial Agents MeSH
- Biocompatible Materials pharmacology MeSH
- Cell Line MeSH
- Chitosan pharmacology MeSH
- Fibroblast Growth Factor 2 pharmacology MeSH
- Fibroblasts drug effects MeSH
- Wound Healing MeSH
- Collagen pharmacology MeSH
- Humans MeSH
- Nanoparticles chemistry therapeutic use MeSH
- Porosity MeSH
- Selenium chemistry pharmacology MeSH
- Materials Testing MeSH
- Tissue Engineering methods MeSH
- Tissue Scaffolds * MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
In a biological system, nanoparticles (NPs) may interact with biomolecules. Specifically, the adsorption of proteins on the nanoparticle surface may influence both the nanoparticles' and proteins' overall bio-reactivity. Nevertheless, our knowledge of the biocompatibility and risk of exposure to nanomaterials is limited. Here, in vitro and ex ovo biocompatibility of naturally based crosslinked freeze-dried 3D porous collagen/chitosan scaffolds, modified with thermostable fibroblast growth factor 2 (FGF2-STAB®), to enhance healing and selenium nanoparticles (SeNPs) to provide antibacterial activity, were evaluated. Biocompatibility and cytotoxicity were tested in vitro using normal human dermal fibroblasts (NHDF) with scaffolds and SeNPs and FGF2-STAB® solutions. Metabolic activity assays indicated an antagonistic effect of SeNPs and FGF2-STAB® at high concentrations of SeNPs. The half-maximal inhibitory concentration (IC50) of SeNPs for NHDF was 18.9 µg/ml and IC80 was 5.6 µg/ml. The angiogenic properties of the scaffolds were monitored ex ovo using a chick chorioallantoic membrane (CAM) assay and the cytotoxicity of SeNPs over IC80 value was confirmed. Furthermore, the positive effect of FGF2-STAB® at very low concentrations (0.01 µg/ml) on NHDF metabolic activity was observed. Based on detailed in vitro testing, the optimal concentrations of additives in the scaffolds were determined, specifically 1 µg/ml of FGF2-STAB® and 1 µg/ml of SeNPs. The scaffolds were further subjected to antimicrobial tests, where an increase in selenium concentration in the collagen/chitosan scaffolds increased the antibacterial activity. This work highlights the antimicrobial ability and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® and SeNPs. Moreover, we suggest that these sponges could be used as scaffolds for growing cells in systems with low mechanical loading in tissue engineering, especially in dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration. Due to their antimicrobial properties, these scaffolds are also highly promising for tissue replacement requiring the prevention of infection.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004455
- 003
- CZ-PrNML
- 005
- 20220127145229.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12951-021-00849-w $2 doi
- 035 __
- $a (PubMed)33849566
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Muchová, Johana $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic
- 245 10
- $a Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation / $c J. Muchová, V. Hearnden, L. Michlovská, L. Vištejnová, A. Zavaďáková, K. Šmerková, S. Kočiová, V. Adam, P. Kopel, L. Vojtová
- 520 9_
- $a In a biological system, nanoparticles (NPs) may interact with biomolecules. Specifically, the adsorption of proteins on the nanoparticle surface may influence both the nanoparticles' and proteins' overall bio-reactivity. Nevertheless, our knowledge of the biocompatibility and risk of exposure to nanomaterials is limited. Here, in vitro and ex ovo biocompatibility of naturally based crosslinked freeze-dried 3D porous collagen/chitosan scaffolds, modified with thermostable fibroblast growth factor 2 (FGF2-STAB®), to enhance healing and selenium nanoparticles (SeNPs) to provide antibacterial activity, were evaluated. Biocompatibility and cytotoxicity were tested in vitro using normal human dermal fibroblasts (NHDF) with scaffolds and SeNPs and FGF2-STAB® solutions. Metabolic activity assays indicated an antagonistic effect of SeNPs and FGF2-STAB® at high concentrations of SeNPs. The half-maximal inhibitory concentration (IC50) of SeNPs for NHDF was 18.9 µg/ml and IC80 was 5.6 µg/ml. The angiogenic properties of the scaffolds were monitored ex ovo using a chick chorioallantoic membrane (CAM) assay and the cytotoxicity of SeNPs over IC80 value was confirmed. Furthermore, the positive effect of FGF2-STAB® at very low concentrations (0.01 µg/ml) on NHDF metabolic activity was observed. Based on detailed in vitro testing, the optimal concentrations of additives in the scaffolds were determined, specifically 1 µg/ml of FGF2-STAB® and 1 µg/ml of SeNPs. The scaffolds were further subjected to antimicrobial tests, where an increase in selenium concentration in the collagen/chitosan scaffolds increased the antibacterial activity. This work highlights the antimicrobial ability and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® and SeNPs. Moreover, we suggest that these sponges could be used as scaffolds for growing cells in systems with low mechanical loading in tissue engineering, especially in dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration. Due to their antimicrobial properties, these scaffolds are also highly promising for tissue replacement requiring the prevention of infection.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $7 D000900
- 650 _2
- $a biokompatibilní materiály $x farmakologie $7 D001672
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a chitosan $x farmakologie $7 D048271
- 650 _2
- $a kolagen $x farmakologie $7 D003094
- 650 _2
- $a fibroblastový růstový faktor 2 $x farmakologie $7 D016222
- 650 _2
- $a fibroblasty $x účinky léků $7 D005347
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a testování materiálů $7 D008422
- 650 _2
- $a nanočástice $x chemie $x terapeutické užití $7 D053758
- 650 _2
- $a poréznost $7 D016062
- 650 _2
- $a selen $x chemie $x farmakologie $7 D012643
- 650 _2
- $a tkáňové inženýrství $x metody $7 D023822
- 650 12
- $a tkáňové podpůrné struktury $7 D054457
- 650 _2
- $a hojení ran $7 D014945
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hearnden, Vanessa $u Department of Materials Science and Engineering, Kroto Research Institute, North Campus, University of Sheffield, Broad Lane, Sheffield, S3 7HQ, UK
- 700 1_
- $a Michlovská, Lenka $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic
- 700 1_
- $a Vištejnová, Lucie $u Biomedical Center, Medical Faculty in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic
- 700 1_
- $a Zavaďáková, Anna $u Biomedical Center, Medical Faculty in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic
- 700 1_
- $a Šmerková, Kristýna $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
- 700 1_
- $a Kočiová, Silvia $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
- 700 1_
- $a Adam, Vojtěch $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
- 700 1_
- $a Kopel, Pavel $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Inorganic Chemistry, Faculty of Science, Palacky University, 17. Listopadu 12, 771 46, Olomouc, Czech Republic
- 700 1_
- $a Vojtová, Lucy $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic. lucy.vojtova@ceitec.vutbr.cz
- 773 0_
- $w MED00008237 $t Journal of nanobiotechnology $x 1477-3155 $g Roč. 19, č. 1 (2021), s. 103
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33849566 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145226 $b ABA008
- 999 __
- $a ok $b bmc $g 1751807 $s 1155604
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 19 $c 1 $d 103 $e 20210413 $i 1477-3155 $m Journal of nanobiotechnology $n J Nanobiotechnology $x MED00008237
- GRA __
- $a 17-29874A $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_019/0000787 $p Ministerstvo Školství, Mládeže a Tělovýchovy
- GRA __
- $a CEITEC VUT/FEKT-J-20-6146 $p Vysoké Učení Technické v Brně
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_025/0007314 $p European Regional Development Fund
- GRA __
- $a NV17-29874A $p MZ0
- LZP __
- $a Pubmed-20220113